NutriBand (NTRB) Long-Term Deferred Tax (2018 - 2026)
NutriBand (NTRB) posted Long-Term Deferred Tax of $5.4 million for Q1 2026, up 21.26% sequentially from $4.4 million in Q1 2025, and up 21.26% YoY from $4.4 million in Q1 2025.
NutriBand (NTRB) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends
NutriBand has reported Long-Term Deferred Tax for 9 years, with the latest figure at $5.4 million in Q1 2026.
- Quarterly Long-Term Deferred Tax rose 21.26% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $5.4 million (up 21.26% YoY) and the FY2026 annual result came in at $5.4 million, up 21.26% from the prior year.
- Long-Term Deferred Tax grew to $5.4 million in Q1 2026 per NTRB's latest filing, from $4.4 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $5.4 million in Q1 2026 and troughed at $1.6 million in Q1 2022.
- A 5-year average of $3.4 million and a median of $3.3 million in 2024 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2022 and 2026: Long-Term Deferred Tax jumped 45.77% in 2022, then gained 21.26% in 2026.
- Over 5 years, Long-Term Deferred Tax stood at $1.6 million in 2022, then surged by 43.65% to $2.3 million in 2023, then surged by 42.99% to $3.3 million in 2024, then surged by 33.88% to $4.4 million in 2025, then grew by 21.26% to $5.4 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $5.4 million, $4.4 million, and $3.3 million for Q1 2026, Q1 2025, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 5.38 Mn |
| Jan 31, 2025 | 4.44 Mn |
| Jan 31, 2024 | 3.31 Mn |
| Jan 31, 2023 | 2.32 Mn |
| Jan 31, 2022 | 1.61 Mn |
| Jan 31, 2021 | 1.11 Mn |
| Jan 31, 2020 | 698,308.00 |
| Jan 31, 2019 | 170,247.00 |
| Jan 31, 2018 | 88,098.00 |